1. Home
  2. TMDX vs PAGP Comparison

TMDX vs PAGP Comparison

Compare TMDX & PAGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • PAGP
  • Stock Information
  • Founded
  • TMDX 1998
  • PAGP 2013
  • Country
  • TMDX United States
  • PAGP United States
  • Employees
  • TMDX N/A
  • PAGP N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PAGP Natural Gas Distribution
  • Sector
  • TMDX Health Care
  • PAGP Energy
  • Exchange
  • TMDX Nasdaq
  • PAGP Nasdaq
  • Market Cap
  • TMDX 3.9B
  • PAGP 3.7B
  • IPO Year
  • TMDX 2019
  • PAGP 2013
  • Fundamental
  • Price
  • TMDX $107.79
  • PAGP $18.58
  • Analyst Decision
  • TMDX Buy
  • PAGP Hold
  • Analyst Count
  • TMDX 10
  • PAGP 8
  • Target Price
  • TMDX $122.11
  • PAGP $20.29
  • AVG Volume (30 Days)
  • TMDX 934.4K
  • PAGP 1.3M
  • Earning Date
  • TMDX 10-27-2025
  • PAGP 11-07-2025
  • Dividend Yield
  • TMDX N/A
  • PAGP 8.17%
  • EPS Growth
  • TMDX 2163.11
  • PAGP N/A
  • EPS
  • TMDX 2.02
  • PAGP 0.69
  • Revenue
  • TMDX $531,292,000.00
  • PAGP $47,796,000,000.00
  • Revenue This Year
  • TMDX $38.86
  • PAGP N/A
  • Revenue Next Year
  • TMDX $20.79
  • PAGP $17.44
  • P/E Ratio
  • TMDX $53.44
  • PAGP $27.01
  • Revenue Growth
  • TMDX 48.09
  • PAGP N/A
  • 52 Week Low
  • TMDX $55.00
  • PAGP $16.61
  • 52 Week High
  • TMDX $169.29
  • PAGP $22.31
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 39.83
  • PAGP 40.42
  • Support Level
  • TMDX $101.00
  • PAGP $18.21
  • Resistance Level
  • TMDX $117.96
  • PAGP $19.32
  • Average True Range (ATR)
  • TMDX 5.07
  • PAGP 0.30
  • MACD
  • TMDX -1.15
  • PAGP -0.03
  • Stochastic Oscillator
  • TMDX 31.08
  • PAGP 33.33

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests

Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.

Share on Social Networks: